CompletedNot Applicable

Comparative Effect of Active Release Technique Versus Self-myofascial Release in Improving Piriformis Syndrome

Pakistan82 participantsStarted 2023-02-03

Plain-language summary

The goal of this Randomized controlled trial is to examine comparative effect of active release technique versus self-myofascial release in improving piriformis syndrome. The main question it aims to answer is: • To compare the effects of Active release technique (ART) and Self-Myofascial release (SMFR) on pain intensity, hip internal rotation and functional disability in patients with piriformis syndrome. Participants will be a given consent form and after subjects read and sign the informed consent, they would be included in study according to eligibility criteria. 2 groups would be included in study, Active release technique will be applied on group A by the physiotherapist and self-myofascial release will be applied on group B by the patients themselves through the use of foam-rollers and massage ball to compare the results of both these techniques on reducing pain, improving range and functional disability among individuals with piriformis syndrome. We will measure outcome through different outcome measure tools.

Who can participate

Age range

20 Years – 40 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 20-40 years * males and females * Pain more than 1 month. * Piriformis syndrome diagnosed through screening tests (FAIR test, Beatty test, Freiberg test, Sign of Pace) * A score ≥8 on a 12-point Clinical scoring system for diagnosis of piriformis syndrome Exclusion Criteria: * Inflammation, malignancy, arthritis, active infection, post-partum or pregnant females and post-op patients, any deformity. * Leg pain due to causes other than piriformis syndrome * Any traumatic History.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Likert pain scale (change is being assessed)

Timeframe: Change from Baseline at 6 weeks

Lower extremity functional scale (change is being assessed)

Timeframe: Change from Baseline at 6 weeks

Range of Motion by Goniometer (change is being assessed)

Timeframe: Change from Baseline range of motion at 6 weeks

Trial details

NCT IDNCT05742633

SponsorSehat Medical Complex

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-05-30

View on ClinicalTrials.gov More Piriformis Syndrome trials

Plain-language summary

Who can participate

Age range

20 Years – 40 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Likert pain scale (change is being assessed)

Timeframe: Change from Baseline at 6 weeks

Lower extremity functional scale (change is being assessed)

Timeframe: Change from Baseline at 6 weeks

Range of Motion by Goniometer (change is being assessed)

Timeframe: Change from Baseline range of motion at 6 weeks